All Journals > Clinical Infectious Diseases > 15 July 2007 > Immunity to S. Typhi in Humans

Article Tools

Search for Related Articles

Announcements

CID LISTED AMONG
“MOST INFLUENTIAL”

Clinical Infectious Diseases has been named as one of the "100 Most Influential Journals in Biology and Medicine" of the past 100 years by the Special Libraries Association. The list was compiled by the 680-plus members of SLA’s Biomedical and Life Sciences Division.

See the full list here.

Source: The DBIO 100, the 100 Most Influential Journals in Biology & Medicine over the last 100 Years

In the News

Featured in MSNBC
"Germs and flu are up; infection control is down" June 9, 2009
Trends in the Incidence of Methicillin‐Resistant Staphylococcus aureus Infection in Children’s Hospitals in the United States
Jeffrey S. Gerber, Susan E. Coffin, Sarah A. Smathers, and Theoklis E. Zaoutis
Just this week, researchers reported that the incidence of MRSA infections among children admitted to pediatric hospitals in the United States more than tripled between 2002 and 2007. Researchers at the Children’s Hospital of Philadelphia and the University of Pennsylvania found cases of MRSA jumped from 6.7 per 1,000 admissions in 2002 to 21.1 cases per 1,000 admissions in 2007, according to a study released online Monday in the journal Clinical Infectious Diseases.

Featured in Toronto Star
"Pigs, viruses and politics" May 2, 2009
Are Swine Workers in the United States at Increased Risk of Infection with Zoonotic Influenza Virus?
Kendall P. Myers, Christopher W. Olsen, Sharon F. Setterquist, Ana W. Capuano, Kelley J. Donham, Eileen L. Thacker, James A. Merchant, and Gregory C. Gray
Another study, this one published in the U.S. journal Clinical Infectious Diseases in 2006, found that workers in meat-processing plants have a greater likelihood of being infected by some version of the H1N1 flu virus than the general population (the odds of pig farmers getting the disease are significantly greater again).

Featured in Philadelphia Inquirer
"A shot in the arm for vaccines" April 19, 2009
Vaccines: Pneumococcal Vaccination of Elderly Adults: New Paradigms for Protection
Lisa A. Jackson and Edward N. Janoff
Every year, an estimated 915,000 people 65 and older get pneumonia, and 40 percent of them end up in hospitals, according to a 2004 paper in the journal Clinical Infectious Diseases. Pneumonia often kills older people, said Richard Stefanacci, a geriatrician at the University of the Sciences in Philadelphia.

15 July 2007 Supplement

Volume 45, Number S1
Clinical Infectious Diseases 2007;45:S15–S19
1058-4838/2007/4502S1-0005$15.00
DOI: 10.1086/518140
SUPPLEMENT ARTICLE

Cell‐Mediated Immunity and Antibody Responses Elicited by Attenuated Salmonella enterica Serovar Typhi Strains Used as Live Oral Vaccines in Humans

Marcelo B. Sztein

Center for Vaccine Development and Departments of Pediatrics and Medicine, University of Maryland School of Medicine, Baltimore

The development of improved typhoid vaccines is a high global public health priority. However, their development has been hampered by a lack of information regarding the specific determinants of protective immunity to Salmonella enterica serovar Typhi (S. Typhi) infection in humans. Although antibodies to S. Typhi O, H, and Vi appear to be involved in protection against S. Typhi infection, it is unknown whether such antibodies mediate protection, act in conjunction with other adaptive responses, or serve as a surrogate for the presence of other, more dominant protective immune responses (e.g., cell‐mediated immunity [CMI]). CMI responses elicited by immunization of subjects with attenuated S. Typhi oral vaccines include lymphoproliferation; production of type 1 cytokines (e.g., interferon‐γ and tumor necrosis factor–α); and classical major histocompatibility complex (MHC) class Ia–restricted and novel, nonclassical MHC class Ib (human leukocyte antigen [HLA]–E)–restricted CD8+ cytotoxic T cell responses. In sum, human immunity to S. Typhi elicited by immunization is unexpectedly broad and complex. However, the immunologic correlates of protection remain largely undefined.

Reprints or correspondence: Dr. Marcelo B. Sztein, Center for Vaccine Development, University of Maryland School of Medicine, 685 W. Baltimore St., HSF1 Rm. 480, Baltimore, MD 21201 ().

Cited by

James E Galen, Marcela F Pasetti, Sharon Tennant, Patricia Ruiz-Olvera, Marcelo B Sztein, Myron M Levine. (2009) Salmonella enterica serovar Typhi live vector vaccines finally come of age. Immunology and Cell Biology 87:5, 400-412
Online publication date: 1-Aug-2009.
CrossRef
R Wahid, R Salerno-Gonçalves, C O Tacket, M M Levine, M B Sztein. (2008) Generation of specific effector and memory T cells with gut- and secondary lymphoid tissue- homing potential by oral attenuated CVD 909 typhoid vaccine in humans. Mucosal Immunology 1:5, 389-398
Online publication date: 1-Oct-2008.
CrossRef
William A. Petri, Mark Miller, Henry J. Binder, Myron M. Levine, Rebecca Dillingham, Richard L. Guerrant. (2008) Enteric infections, diarrhea, and their impact on function and development. Journal of Clinical Investigation 118:4, 1277-1290
Online publication date: 1-May-2008.
CrossRef
Close Popup